Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
231 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (32)
  • Closed (169)

Medical Condition

  • Show all (1747)
  • Addiction (18)
  • Allergy, Asthma, & Immunology (13)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (29)
  • Blood Disorders (33)
  • Bone & Muscle (10)
  • Cancer (564)
    • Bladder Cancer (13)
    • Brain Cancer (12)
    • Breast Cancer (60)
    • Gastrointestinal (10)
    • Gynecologic Cancer (30)
    • Head and Neck Cancer (4)
    • Kidney Cancer (7)
    • Leukemia (64)
    • Liver Cancer (4)
    • Lung Cancer (57)
    • Lymphoma (24)
    • Multiple Myeloma (24)
    • Pancreatic Cancer (6)
    • Prostate Cancer (25)
    • Sarcoma (23)
    • Skin Cancer (26)
    • (-) Solid Tumors (36)
    • Thyroid Cancer (1)
    • Uveal Melanoma (7)
  • Child Development (4)
  • COVID-19 (Coronavirus) (36)
  • Critical Illness (1)
  • Diabetes (21)
  • Ear, Nose and Throat (11)
  • Endocrine & Metabolic Disease (12)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (26)
  • Hair and Skin Disorders (3)
  • Headaches (5)
  • Healthy Volunteers (185)
  • Heart Disease (130)
  • Infectious Disease (49)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (53)
  • Lung Disease (31)
  • Meniere's Disease (1)
  • (-) Neurological Disorders (165)
    • Alzheimer's Disease (39)
    • Brain Tumors (44)
    • Cerebral Palsy (2)
    • Dementia (8)
    • Huntington's Disease (3)
    • Multiple Sclerosis (8)
    • Neuromuscular (12)
    • Neuropathy (12)
    • Parkinson's Disease (3)
  • Nutrition (6)
  • Obesity (10)
  • Obstetrics & Gynecology (56)
  • Pain Management (1)
  • Pediatrics (102)
  • Psychiatric Disorders (67)
  • Rehabilitation (8)
  • Stroke (7)
  • Surgery (7)
  • Transplant (47)
  • Urology (4)
  • Vascular Conditions (10)
Displaying 201 - 201 of 201

A study for patients with locally advanced or metastatic solid tumors using study drug demcizumab

Condition: Cancer / Solid Tumors
Investigator: Catherine Shu, MD
Status: Closed
The purpose of this study is to test the efficacy and safety of an experimental drug, demcizumab, when given in combination with pembrolizumab (Arm A of the study). Demcizumab is a humanized monoclonal antibody and was developed to target cancer stem cells. Demcizumab may block the growth of cancer stem cells, in addition to the remaining cancer cells, and…
Read More

Pagination

  • Previous page ‹‹
  • Page 2
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science